Let's Fix The Patent-Specific Preliminary Injunction Test
For pioneering biopharmaceutical companies, the ability to exclude a generic competitor from the marketplace is vital. The post-stay entry of a generic often permanently destroys the market pricing on which the...To view the full article, register now.
Already a subscriber? Click here to view full article